Protalix Biotherapeutics Inc (PLX)
Net Income Growth
201.91%
TTM · Period ending:
PLX Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported201.91%period ending
Latest reported201.91%period ending
PLX TTM Net Income YoY % (-392.31% → 201.91%)
Year-over-year change
High-resolution chart · PNG
PLX net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| 201.9124% | |
| 292.3234% | |
| -325.2387% | |
| 156.1524% | |
| 142.7045% | |
| -42.9322% | |
| -64.7257% | |
| -190.4861% | |
| -265.0826% | |
| 143.4187% | |
| 155.6843% | |
| 159.4601% | |
| 148.15% | |
| 35.3421% | |
| 45.8814% | |
| 12.9837% | |
| 10.9366% | |
| -78.5071% | |
| -322.8423% | |
| -209.5188% | |
| -260.8484% | |
| -46.2279% | |
| 64.3084% | |
| 24.5504% | |
| 45.4683% | |
| 17.0587% | |
| -62.5689% | |
| 75.7051% | |
| 75.0514% | |
| 66.2331% | |
| 86.8169% | |
| 50.2962% | |
| 38.3796% | |
| 58.2469% | |
| -190.4001% | |
| -83.4199% | |
| -89.5464% | |
| -162.74% | |
| -5.6675% | |
| -70.0154% | |
| -31.5239% | |
| -6.4613% | |
| 7.1903% | |
| 27.8964% | |
| 8.5526% | |
| 7.2824% | |
| -7.7474% | |
| -20.8237% | |
| -13.5098% | |
| -56.7744% | |
| -30.8504% | |
| -32.1002% | |
| -12.0152% | |
| 47.4198% | |
| 41.8599% | |
| 43.9077% | |
| 20.4182% | |
| -43.2497% | |
| -25.9708% | |
| -2.0844% | |
| 23.3941% | |
| 23.7256% | |
| 7.7672% | |
| -53.4055% | |
| -63.9473% | |
| -52.1615% | |
| -40.2695% | |
| -10.0672% | |
| -23.2218% | |
| 6.8754% | |
| 0.298% | |
| 21.32% | |
| 21.2465% | |
| -29.2713% | |
| -33.9271% | |
| -255.117% | |
| -384.4182% | |
| -1,050.3648% | |
| -22,302.2421% | |
| -8,563.7075% | |
| -5,042.2873% | |
| -1,029.5593% | |
| 53.1892% | |
| 50.4193% | |
| 40.1463% | |
| -6.5335% | |
| -13.7556% | |
| -21.1627% | |
| -13.5879% | |
| 7.8988% | |
| 6.0416% | |
| 7.656% | |
| 16.3766% | |
| 23.9667% | |
| 54.467% | |
| 53.7256% | |
| 37.7231% | |
| 18.4385% | |
| -211.4403% | |
| 19.3281% |